Skip to main content
. 2022 Aug 16;7(5):e00290-22. doi: 10.1128/msphere.00290-22

TABLE 1.

TB_KKG6K-induced leakage of microbial model membranesa

Model Lipid(s) and location % Leakage
TB_KKG6K
PCγC-terminal (32 μM)
2 μM 4 μM 8 μM
Prokaryotic membrane PG 56.0 ± 4.0* (+40) 57.7 ± 3.9* (+30) 61.1 ± 4.1* (+20) 1.9 ± 1
PG-PE-CL 5.3 ± 1.3 40.2 ± 0.9 61.5 ± 2.7 −1.2 ± 1.6
Eukaryotic membrane PC 33.8 ± 3.0 40.6 ± 3.2 49.2 ± 4.5 1.4 ± 1.4
Outer leaflet
 PC-sphingomyelin 18.8 ± 3.1* (−44) 26.5 ± 1.0* (−34) 33.9 ± 2.0* (−31) 0.6 ± 0.8
 PC-ceramide 17.9 ± 1.8* (−47) 39.9 ± 2.4 44.8 ± 1.9 1.3 ± 0.2
Inner leaflet
 PC-PI 37.7 ± 3.9 52.5 ± 2.4* (+29) 56.5 ± 2.9* (+15) 0.4 ± 0.5
 PC-PE 22.8 ± 1.3* (−32) 31.5 ± 2.1* (−22) 40.0 ± 3.1* (−19) 1.4 ± 0.6
 PC-PS 22.6 ± 3.3* (−33) 38.1 ± 10.5 47.4 ± 15.1 0.9 ± 2.7
 PC-ergosterol 9.8 ± 1.5* (−71) 13.0 ± 0.6* (−68) 16.9 ± 2.0* (−66) 1.1 ± 0.9
 PC-PE-ergosterol 14.8 ± 0.8* (−56) 17.1 ± 6.0* (−58) 15.8 ± 1.3* (−68) 1.7 ± 2.0
 PC-PS-ergosterol 21.8 ± 3.5* (−36) 30.1 ± 4.6* (−26) 46.3 ± 4.2 2.0 ± 1.4
Mitochondrial envelope
 PC-CL 2.2 ± 0.8* (−93) 9.9 ± 0.7* (−75) 59.0 ± 5.8* (+20) 0.7 ± 0.4
a

Data represent leakage of 50 μM concentrations of model membranes composed of different lipids in response to exposure to 2 μM, 4 μM, or 8 μM TB_KKG6K, which corresponded to lipid:peptide molar ratios of 25:1, 12:1, and 6:1, respectively, determined after 30 min of incubation at 37°C. Data are relative mean ± SD leakage of two independent experiments performed in duplicates in the presence of the TB analog. The values were compared to those for the positive control (1% [wt/vol]) Triton-X), which represented 100% leakage. The relative change (as a percentage) in leakage of the different lipid combinations was compared to the values for PC-LUVs (in parentheses). PCγC-terminal (32 μM; lipid:peptide molar ratio of 1.5:1) served as a negative control. A two-way ANOVA, corrected for multiple comparisons by the Dunnett's test, was applied to calculate the significant differences between the mean leakage values of LUVs composed of distinct lipid formulations to those of the PC-LUVs. *, P ≤ 0.05.